Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Clin Cancer Res. 2017 Jul 21;23(23):7158–7164. doi: 10.1158/1078-0432.CCR-17-1069

Table 1.

Zone and Arm Designation by Combination

Venetoclax
(mg per day)
400 Zone 2/Arm C Zone 3/Arm E Zone 4/Arm F
200 Zone 1/Arm A Zone 2/Arm B Zone 3/Arm D
280 420 560
ibrutinib (week 1+) mg per day